CRCristiano Rossitto

Cristiano Rossitto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cristiano Rossitto has a total of 102 co-authors. Here are the top co-authors by number of shared publications:

  • Francesco Fanfani

    Department of Women, Children and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    31 shared publications
  • Giovanni Scambia

    Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Institute of Obstetrics and Gynecology, Universita' Cattolica del Sacro Cuore, Rome, Italy

    30 shared publications
  • Salvatore Gueli Alletti

    Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy

    19 shared publications
  • Valerio Gallotta

    Department of Women's and Children's Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    18 shared publications
  • Anna Fagotti

    Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Institute of Obstetrics and Gynecology, Universita' Cattolica del Sacro Cuore, Rome, Italy

    16 shared publications
  • Barbara Costantini

    Department of Women, Children and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Saint Camillus International, University of Health Sciences, Rome, Italy

    9 shared publications

Latest Publications

  • Open Access

    P-023 Initial experience with transcranial ultrasound through sonolucent cranioplasty after hemicraniectomy for ischemic and hemorrhagic stroke

    by C Rossitto, H Tabani, A Reynolds, C Kellner

    Introduction Neurosurgery is a field which embraces innovation, yet, the use of ultrasound has been adapted more slowly than other specialties. Diagnostic ultrasound has several advantages, including low cost, point-of-care accessibility, and lack of radiation exposure. Recently, advances in types of cranioplasty implants are creating new windows to perform transcranial ultrasound. Materials and Methods Consecutive patients who underwent decompressive hemicraniectomy (DHC) followed by cranioplasty with custom clear polymethyl methacrylate implant based on computed tomography were included. Postoperative sonography was performed and findings were recorded. Patient demographics including age, gender, indication, infection rate, and revision rates were analyzed. Results Five consecutive patients (60% female, median age 57 years [IQR 46-62]) underwent cranioplasty. The underlying pathology prompting DHC was ruptured arteriovenous malformations (2), hypertensive intracerebral hemorrhages (2) and ischemic stroke (1). Image quality varied by operator, ultrasound system, and postoperative changes. There were no incision infections or cranioplasty revisions. Conclusion Transcranial ultrasound through large, customized sonolucent cranioplasty is safe and feasible after decompressive hemicraniectomy. This imaging technique may alleviate the cost, transport, and radiation burden of CT in select ICH patients. Disclosures C. Rossitto: None. H. Tabani: None. A. Reynolds: None. C. Kellner: 1; C; CPK receives research funding from Longeviti Neuro Solutions, Penumbra, Integra, Viz.AI, Minnetronix, Siemens, and Cerebrotech.

  • Open Access

    E-249 Use of the scepter mini in management of cerebrovascular malformations: a single-center experience and review of indications

    by A Devarajan, J Zhang, D Goldman, M Al-Kawaz, H Tabani, C Rossitto, R De Leacy, C Kellner, A Berenstein, J Fifi, et al.

    Introduction Balloon assistance has been utilized to enhance the efficacy of endovascular embolization of cerebrovascular malformations. Recently, the advent of dual-lumen balloon catheters (DLBC) has allowed for simultaneous flow arrest and the injection of liquid embolic agents (LEA) for embolization without reflux or the creation of a proximal plug. To maximize safety and efficacy in embolization, the balloon should be placed as close as possible to the target pathology. The Scepter Mini is a new dual-lumen microballoon catheter which offers a softer balloon and smaller diameter than previous DLBCs to catheterize small-caliber distal intracranial vasculature. Here, we report on our institution’s experience with the Scepter Mini microcatheter. Methods A single-center retrospective chart review identified all patients with cerebrovascular cerebrovascular pathology (dural arteriovenous fistulas, Vein of Galen Malformations, arteriovenous malformations, intracranial aneurysms, subdural hematomas, and tumor embolizations) treated with the Scepter Mini. Clinical data, structural and hemodynamic characteristics of the pathology, and technical parameters including anatomic approach, LEA used, complications and embolization success were reviewed. Results 110 Scepter Mini microcatheters were used during 80 procedures in the treatment of 13 pediatric and 53 adult patients. The most common pathology treated with the Scepter Mini was dural arteriovenous fistulas (29/80 procedures). 75/80 procedures were performed by transarterial approach, and the Scepter Mini was used for embolization in all but one instance where it was used as balloon assistance for the coiling of a ruptured aneurysm. Technical success was achieved in 96.3% of all cases. Near-tip entrapment of the Scepter Mini occurred in 1/110 (0.9%) uses of the catheter, which was successfully retrieved without further complication. Clinical complications unrelated to the Scepter Mini occurred postoperatively in 8/80 cases and no intraoperative reflux or vessel rupture was noted. Conclusion We report the largest cohort to date of Scepter Mini usage in the treatment of cerebrovascular malformations. The Scepter Mini is an important tool in the treatment of cerebrovascular pathology requiring extremely distal access and allows for the safe utilization of LEAs in high-flow pathology or small-caliber tortuous vasculature. Disclosures A. Devarajan: None. J. Zhang: None. D. Goldman: None. M. Al-Kawaz: None. H. Tabani: None. C. Rossitto: None. R. De Leacy: None. C. Kellner: None. A. Berenstein: 2; C; Microvention. J. Fifi: 2; C; Microvention. T. Shigematsu: None.

  • Open Access

    E-170 Transvenous embolization with pressure cooker technique offers successful angiographic cure of vein of galen malformations with favorable clinical outcomes

    by A Devarajan, T Shigematsu, H Tabani, A Schupper, C Rossitto, J Bonet, M Sorscher, P Morgenstern, S Ghatan, A Berenstein, et al.

    Introduction Vein of Galen Malformations (VOGM) are congenital arteriovenous malformations (AVM) which are primarily treated by endovascular embolization. Current treatment involves staged transarterial embolization (TAE) for progressive obliteration of the fistula. However, TAE alone does not always completely close the malformation. To close the malformation and achieve angiographic cure, these staged TAEs can be followed by a final curative transvenous embolization (TVE). The pressure cooker technique (PCT) has gained popularity as a novel and effective TVE technique for the curative embolization of high-flow AVMs. Here, we aim to characterize the angiographic and clinical outcomes of a large cohort of patients who were cured of VOGM with a final curative embolization by PCT. Methods A retrospective chart review at two high-volume endovascular centers identified all patients with VOGM who were cured by TVE using the pressure cooker technique. Initial clinical presentation, presentation at TVE, clinical and angiographic outcomes, and technical parameters were reviewed. Results 15 patients were treated for their VOGM with a final curative TVE by PCT. All patients had a choroidal VOGM (15/15, 100%) which had been previously embolized by staged TAE. Patients initially presented at a median age of 8 months with hydrocephalus, congestive heart failure, and developmental delay. The median age at TVE was 3.614 years and patients presented with hemiplegia, seizures, developmental delay, and persistent hydrocephalus. Technical success was achieved in 100% of PCTs (15/15). Postoperatively, two patients experienced small intraventricular hemorrhage requiring subsequent EVD placement, but recovered without permanent neurologic deficit. All 11 patients who have received follow-up angiograms continue to demonstrate complete obliteration of the malformation. On clinical follow-up, all patients (15/15, 100%) were either asymptomatic or demonstrated notable progression in milestones. Conclusion The pressure cooker technique offers an attractive option to achieve curative embolization of VOGM by TVE. Patients who received curative embolization using PCT demonstrated persistent angiographic cure and excellent clinical outcomes even at long-term clinical follow-up. Disclosures A. Devarajan: None. T. Shigematsu: None. H. Tabani: None. A. Schupper: None. C. Rossitto: None. J. Bonet: None. M. Sorscher: None. P. Morgenstern: None. S. Ghatan: None. A. Berenstein: None. R. Chapot: None. J. Fifi: None.

  • Open Access

    E-085 The scepter mini catheter allows for improved penetration of fine vascular networks and facilitates curative embolization in vein of galen malformations

    by A Devarajan, A Schupper, C Rossitto, J Bonet, M Sorscher, P Morgenstern, S Ghatan, T Shigematsu, A Berenstein, J Fifi

    Introduction Patients with Vein of Galen malformations (VOGM) can develop significant angiogenesis leading to hemodynamic and structural remodeling. This results in an extensive fine angiogenic network with fistulous connections to the vein of Galen. In patients with angiogenic networks, transarterial embolization (TAE) with liquid embolic agents (LEA) is challenging due to poor penetration and access, while transvenous approaches carry a risk of hemorrhage from pathologic vasculature. Dual-lumen balloon microcatheters such as the Scepter Mini (Microvention, Aliso Viejo, CA) improve navigability and distal pedicle access in small vessels. Here, we report on the novel use of the Scepter Mini for TAE of angiogenic VOGM. Methods A single-institution retrospective chart review identified all patients with VOGM treated with Scepter Mini balloon microcatheters. Clinical data, angioarchitecture pre-embolization and post-embolization, and technical parameters including complications and embolization success were reviewed. Results 17 Scepter Mini catheters were used in 12 embolizations of seven patients with VOGM. The median patient age at embolization was 2.10 years old. Patients presented with hydrocephalus (n=7, 100%) and gross motor and speech delays (n=4, 57.14%). Anatomically, fine vascular networks developed extra-axially into the subependymal zone from the posterior choroidal, posterior cerebral, and thalamoperforator arteries. Distal access to the network and VOGM was most commonly achieved within posterior choroidal branches (n=5/17, 29.41%). Successful embolization with Onyx-18 was achieved in 17/17 (100%) uses with all patients angiographically demonstrating significant network penetration. Near tip entrapment of the Scepter Mini with concurrent significant LEA cast displacement on removal occurred in 1/17 uses. One patient experienced postprocedural intraventricular hemorrhage requiring third ventriculostomy without permanent neurologic deficit. Conclusions The Scepter Mini provided excellent distal access with penetration to the fistula and subsequent extra-axial network reduction with few complications. The Scepter Mini provides a means for successful treatment of angiogenic VOGM who present early and symptomatically, facilitating curative embolization. Disclosures A. Devarajan: None. A. Schupper: None. C. Rossitto: None. J. Bonet: None. M. Sorscher: None. P. Morgenstern: None. S. Ghatan: None. T. Shigematsu: None. A. Berenstein: 2; C; Microvention. J. Fifi: 2; C; Microvention.

  • Feasibility and perioperative outcomes of percutaneous-assisted laparoscopic hysterectomy: A multicentric Italian experience

    by Salvatore Gueli Alletti, Emanuele Perrone, Antonio Cretì, Stefano Cianci, Stefano Uccella, Camilla Fedele, Francesco Fanfani, Stefano Palmieri, Anna Fagotti, Giovanni Scambia, et al.


  • Laparoscopic Management of Abdominal Pregnancy

    by Francesco Cosentino, Cristiano Rossitto, Luigi Carlo Turco, Salvatore Gueli Alletti, Carmine Vascone, Lavinia Di Meglio, Giovanni Scambia, Mario Malzoni


  • Needleoscopic Conservative Staging of Borderline Ovarian Tumor

    by Salvatore Gueli Alletti, Cristiano Rossitto, Emanuele Perrone, Stefano Cianci, Ilaria De Blasis, Anna Fagotti, Giovanni Scambia


  • Total Laparoscopic (S-LPS) versus TELELAP ALF-X Robotic-Assisted Hysterectomy: A Case-Control Study

    by Francesco Fanfani, Stefano Restaino, Cristiano Rossitto, Salvatore Gueli Alletti, Barbara Costantini, Giorgia Monterossi, Serena Cappuccio, Emanuele Perrone, Giovanni Scambia


  • Total laparoscopic hysterectomy using a percutaneous surgical system: a pilot study towards scarless surgery

    by Cristiano Rossitto, Salvatore Gueli Alletti, Stefano Rotolo, Stefano Cianci, Giovanni Panico, Giovanni Scambia